LENSAR Inc (LNSR) - Total Liabilities
Based on the latest financial reports, LENSAR Inc (LNSR) has total liabilities worth $82.33 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
LENSAR Inc - Total Liabilities Trend (2018–2024)
This chart illustrates how LENSAR Inc's total liabilities have evolved over time, based on quarterly financial data. See LNSR net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LENSAR Inc Competitors by Total Liabilities
The table below lists competitors of LENSAR Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Brixton Metals Corporation
V:BBB
|
Canada | CA$1.94 Million |
|
Vakrangee Limited
NSE:VAKRANGEE
|
India | Rs1.25 Billion |
|
Noodles & Company
NASDAQ:NDLS
|
USA | $294.36 Million |
|
Malaysian Bulk Carriers Bhd
KLSE:5077
|
Malaysia | RM149.61 Million |
|
Moulinvest
PA:ALMOU
|
France | €64.85 Million |
|
Agabang&Company
KQ:013990
|
Korea | ₩58.80 Billion |
|
Kukdong Oil &
KO:014530
|
Korea | ₩271.00 Billion |
|
Lowell Resources Fund
AU:LRT
|
Australia | AU$2.41 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down LENSAR Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LENSAR Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -6.79 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LENSAR Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LENSAR Inc (2018–2024)
The table below shows the annual total liabilities of LENSAR Inc from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $47.65 Million | +112.64% |
| 2023-12-31 | $22.41 Million | +61.68% |
| 2022-12-31 | $13.86 Million | +19.63% |
| 2021-12-31 | $11.59 Million | -2.72% |
| 2020-12-31 | $11.91 Million | -81.70% |
| 2019-12-31 | $65.09 Million | +31.89% |
| 2018-12-31 | $49.35 Million | -- |
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcom… Read more